−0.0187 USD
−8.06 M USD
39.52 K USD
226.40 M
About Axim Biotechnologies, Inc.
AXIM Biotechnologies, Inc. operates as a biotechnology company, which engages in the development of diagnostic healthcare solutions. Its product categories include Eye Health, SARS-CoV-2, and fentanyl neutralizing antibody test. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.
AXIM Biotechnologies: But opportunity above the 1W MA50.AXIM has turned bullish on the 1W chart (RSI = 64.496, MACD = 0.100, ADX = 26.272) as after the break-out above the 1W MA50 (blue line), it is now on the 3rd straight week of trading above it. This is the first sustainable sequence above the MA50 in years, supported by a strong RSI. That break-out w
Random play on an oversoldI call this my lotto play. Oversold biotech with cannabis roots deep in the business model. With the recent news why not ?
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AXIM is 0.0019 USD — it has increased by 5.56% in the past 24 hours. Watch Axim Biotechnologies, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Axim Biotechnologies, Inc. stocks are traded under the ticker AXIM.
AXIM stock hasn't changed in a week, the month change is a −13.64% fall, over the last year Axim Biotechnologies, Inc. has showed a −90.50% decrease.
AXIM reached its all-time high on Jan 12, 2017 with the price of 19.8000 USD, and its all-time low was 0.0013 USD and was reached on Dec 11, 2024. View more price dynamics on AXIM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AXIM stock is 11.11% volatile and has beta coefficient of −3.54. Track Axim Biotechnologies, Inc. stock price on the chart and check out the list of the most volatile stocks — is Axim Biotechnologies, Inc. there?
Today Axim Biotechnologies, Inc. has the market capitalization of 573.72 K, it has decreased by −2.42% over the last week.
Yes, you can track Axim Biotechnologies, Inc. financials in yearly and quarterly reports right on TradingView.
AXIM net income for the last quarter is −533.77 K USD, while the quarter before that showed −2.27 M USD of net income which accounts for 76.48% change. Track more Axim Biotechnologies, Inc. financial stats to get the full picture.
No, AXIM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 29, 2024, the company has 7.00 employees. See our rating of the largest employees — is Axim Biotechnologies, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Axim Biotechnologies, Inc. EBITDA is −1.72 M USD, and current EBITDA margin is −5.88 K%. See more stats in Axim Biotechnologies, Inc. financial statements.
Like other stocks, AXIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Axim Biotechnologies, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Axim Biotechnologies, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Axim Biotechnologies, Inc. stock shows the sell signal. See more of Axim Biotechnologies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.